Peer review report 1 on “Percutaneous compression plate versus dynamic hip screw for treatment of intertrochanteric hip fractures: A overview of systematic reviews and update meta-analysis of randomized controlled trials”

2016 ◽  
Vol 25 ◽  
pp. 312
Keyword(s):  
Randomized Controlled Trials ◽  
Hip Fractures ◽  
Meta Analysis ◽  
Plate Versus ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Compression Plate ◽  
Overview Of Systematic Reviews ◽  
Hip Screw ◽  
Percutaneous Compression Plate

scholarly journals Percutaneous Compression Plate versus Dynamic Hip Screw for Treatment of Intertrochanteric Hip Fractures: A Meta-Analyse of Five Randomized Controlled Trials

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Lei Zhang ◽  
Jie Shen ◽  
Shengpeng Yu ◽  
Qiang Huang ◽  
Zhao Xie
Keyword(s):  
Blood Loss ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Operation Time ◽  
Dynamic Hip Screw ◽  
Plate Versus ◽  
Controlled Trials ◽  
Intertrochanteric Fractures ◽  
Randomized Controlled ◽  
Hip Screw

Background. Percutaneous compression plating (PCCP) has been advocated to reduce blood loss, relieve pain, and lead to faster rehabilitation for the treatment of intertrochanteric fractures. The purpose of this meta-analysis was to estimate the outcomes and complications of the PCCP versus dynamic hip screw (DHS) fixation for intertrochanteric fractures.Methods. All randomized controlled trials (RCT) that compared PCCP with DHS in treating adult patients with intertrochanteric fractures were included. Main outcomes were collected and analysed using the RevMan 5.1 version.Results. Five trials met the inclusion criteria. Compared with DHS, PCCP had similar operation time (95% CI: −26.01~4.05,P= 0.15), length of hospitalization (95% CI: −1.79~1.25,P= 0.73), mortality (95% CI: 0.37~1.02,P= 0.06), incidence of implant-related complications (95% CI: 0.29~1.82,P= 0.49), and reoperation rate (95% CI: 0.41~3.05,P= 0.83). But blood loss (95% CI: −173.84~−4.81,P= 0.04) and transfusion need (95% CI: −0.53~−0.07,P= 0.01) significantly favored the PCCP.Conclusions. The PCCP was associated with reduced blood loss and less transfusion need, but similar to DHS in other respects. Owing to the limitations of this systematic review, more high-quality RCTs are still needed to assess the clinical efficiency of PCCP.

scholarly journals Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials

PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0194801 ◽  
Author(s):  
Fernanda O. Laranjeira ◽  
Keitty R. C. de Andrade ◽  
Ana C. M. G. Figueiredo ◽  
Everton N. Silva ◽  
Mauricio G. Pereira
Keyword(s):  
Type 1 Diabetes ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Insulin Analogues ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Acting Insulin ◽  
Overview Of Systematic Reviews ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document